FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

アメリカ食品医薬品局には、市販薬と処方薬の審査を担当する部局として「医薬品評価研究センター (CDER)」という部署があり、「cderGPT」という名称はCDERから取られたものと考えられます。 Center for Drug Evaluation ...

The Food and Drug Administration is going all in on artificial intelligence. Commissioner Martin Makary, M.D., has instructed all the agency’s centers to fully integrate generative AI into their ...

FDAは輸入審査に生成AIツールを活用 同サミットで米国食品医薬品局（FDA）は、水際での旅客や貨物の審査に生成人工知能（AI）を活用すると発表 ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

However, trust gaps among clinicians and patients are threatening to slow the adoption and impact of AI. Among HCPs, ...

Read about the House Energy and Commerce Committee's budget text, which includes funding for Commerce's federal IT ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of constantly ...